These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Controlled drug release from poly(ortho esters). Heller J Ann N Y Acad Sci; 1985; 446():51-66. PubMed ID: 3925854 [No Abstract] [Full Text] [Related]
3. Long-term controlled delivery of levonorgestrel in rats by means of small biodegradable cylinders. Wise DL; Rosenkrantz H; Gregory JB; Esber HJ J Pharm Pharmacol; 1980 Jun; 32(6):399-403. PubMed ID: 6106671 [TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery. Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S Int J Pharm; 2011 Feb; 404(1-2):10-8. PubMed ID: 21047548 [TBL] [Abstract][Full Text] [Related]
6. [Intravitreal drug delivery by microspheres of biodegradable polymers]. Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493 [TBL] [Abstract][Full Text] [Related]
7. In vivo degradation and biocompatibility study of in vitro pre-degraded as-polymerized polyactide particles. Bergsma JE; Rozema FR; Bos RR; Boering G; de Bruijn WC; Pennings AJ Biomaterials; 1995 Mar; 16(4):267-74. PubMed ID: 7772665 [TBL] [Abstract][Full Text] [Related]
8. Biodegradable poly(DL-lactic acid) formulations in a calcitonin delivery system. Asano M; Yoshida M; Omichi H; Mashimo T; Okabe K; Yuasa H; Yamanaka H; Morimoto S; Sakakibara H Biomaterials; 1993 Aug; 14(10):797-9. PubMed ID: 8218732 [TBL] [Abstract][Full Text] [Related]
9. In vivo characteristics of low molecular weight copoly (D,L-lactic acid) formulations with controlled release of LH-RH agonist. Asano M; Fukuzaki H; Yoshida M; Kumakura M; Mashimo T; Yuasa H; Imai K; Yamanaka H Biomaterials; 1989 Oct; 10(8):569-73. PubMed ID: 2513891 [TBL] [Abstract][Full Text] [Related]
11. Mechanical properties of biodegradable ligament augmentation device of poly(L-lactide) in vitro and in vivo. Laitinen O; Törmälä P; Taurio R; Skutnabb K; Saarelainen K; Iivonen T; Vainionpää S Biomaterials; 1992; 13(14):1012-6. PubMed ID: 1472587 [TBL] [Abstract][Full Text] [Related]
12. Enhanced biocompatibility and wound healing properties of biodegradable polymer-modified allyl 2-cyanoacrylate tissue adhesive. Lee YJ; Son HS; Jung GB; Kim JH; Choi S; Lee GJ; Park HK Mater Sci Eng C Mater Biol Appl; 2015 Jun; 51():43-50. PubMed ID: 25842106 [TBL] [Abstract][Full Text] [Related]
13. Implantable biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathy. Hashizoe M; Ogura Y; Takanashi T; Kunou N; Honda Y; Ikada Y Curr Eye Res; 1995 Jun; 14(6):473-7. PubMed ID: 7671629 [TBL] [Abstract][Full Text] [Related]
14. A new vitreal drug delivery system using an implantable biodegradable polymeric device. Kimura H; Ogura Y; Hashizoe M; Nishiwaki H; Honda Y; Ikada Y Invest Ophthalmol Vis Sci; 1994 May; 35(6):2815-9. PubMed ID: 8188476 [TBL] [Abstract][Full Text] [Related]
15. Degradation of and tissue reaction to biodegradable poly(L-lactide) for use as internal fixation of fractures: a study in rats. Bos RR; Rozema FR; Boering G; Nijenhuis AJ; Pennings AJ; Verwey AB; Nieuwenhuis P; Jansen HW Biomaterials; 1991 Jan; 12(1):32-6. PubMed ID: 2009343 [TBL] [Abstract][Full Text] [Related]
16. [Preparation of ibuprofen/sPEG-b-PLLA copolymer microspheres and its in vitro release properties]. Lin YL; Zhang AQ; Guan FY; Chen YD; Tan WA; Wang LS Yao Xue Xue Bao; 2010 Dec; 45(12):1570-5. PubMed ID: 21351499 [TBL] [Abstract][Full Text] [Related]